Keyphrases
Medicare Advantage
100%
Oral Antidiabetic Drugs
100%
Diabetes Medications
100%
Risk Prediction Tool
100%
Managed Care Organization
60%
Non-adherent
40%
Medicaid
40%
Medicare
40%
Prescription Drugs
40%
Non-adherence
40%
Prediction Value
40%
Star Rating
40%
Texas
20%
Dipeptidyl peptidase-4 (DPP-4)
20%
Sulfonylurea
20%
Intervention Program
20%
Diabetes Diagnosis
20%
Area under the Curve
20%
Thiazolidinediones
20%
Targeted Intervention
20%
Low Adherence
20%
Insulin
20%
Baseline Period
20%
Pharmacist
20%
Houston
20%
Biguanides
20%
Medication Adherence
20%
Proportion of Days Covered
20%
Retrospective Observational Study
20%
Claims Data
20%
Adherence Measures
20%
Risk Assessment Tool
20%
Prediction Skill
20%
Effective Tool
20%
Internal Validity
20%
Medicare Claims Data
20%
Meglitinides
20%
Drug Program
20%
Negative Predictions
20%
Medicare Population
20%
Prediction Tool
20%
Adherence Prediction
20%
Medicine and Dentistry
Diabetes
100%
Medicare
100%
Drug Therapy
100%
Oral Antidiabetic Agent
83%
Observational Study
16%
Medication Compliance
16%
Prescription Medication
16%
Prescription Drug
16%
Meglitinide
16%
Sulfonylurea
16%
Biguanide Derivative
16%
Thiazolidinedione
16%
Dipeptidyl Peptidase-4 Inhibitor
16%
Nursing and Health Professions
Drug Therapy
100%
Medicare
100%
Oral Antidiabetic Agent
83%
Managed Care Organization
50%
Prescription Drug
16%
Area under the Curve
16%
Medication Compliance
16%
Internal Validity
16%
Biguanide Derivative
16%
Thiazolidinedione
16%
Meglitinide
16%
Dipeptidyl Peptidase IV Inhibitor
16%
Sulfonylurea
16%
Pharmacology, Toxicology and Pharmaceutical Science
Oral Antidiabetic Agent
100%
Dipeptidyl Peptidase IV Inhibitor
20%
Sulfonylurea
20%
Thiazolidinedione
20%
Prescription Drug
20%
Observational Study
20%
Prescription Medication
20%
Meglitinide
20%
Biguanide Derivative
20%